Precision Medicine in Action: Launching Pharmacogenomics & Nutrigenomics in RSU Royal Prima, Medan
Medan, North Sumatra, Indonesia
In Collaboration with RSU Royal Prima Medan
- Prof. Dr. Tommy Leonard, SH, M.Kn., President Director, PT Royal Prima, Tbk
- Dr. dr. Wienaldi, MKM, MQM, President Director, RSU Royal Prima
- Ridyawati, S.Ak, MM, General Manager, RSU Royal Prima
- Indrida Rahmi, SH, M.Kn., Corporate Secretary & Legal Officer, PT Royal Prima, Tbk
- Dr. Rebecca Tay, CEO, Global Precision Diagnostics
- Dr. Gew Soon Peng, COO, Global Precision Diagnostics
- Ms. Maria Phang, Operations Director, Global Precision Diagnostics
- Ms. Nanny Sukimin, CEO, Medis Online & Regional Account Lead, Global Precision Diagnostics
- Along with other distinguished guests and clinicians
The health landscape of Medan
With the introduction of Pharmacogenomics testing, patients in Medan can now receive:
● Genetic information to personalize medication choices
● Reduced risk of adverse drug reactions
● More precise, evidence-based care
Our Nutrigenomics testing further enables individuals to make informed decisions on nutrition, supplementation, and lifestyle, based on their unique genetic profile.
This partnership reflects a shared vision to transform diagnostics and preventive care across Indonesia, bringing us one step closer to a future where healthcare is more precise, predictive, and patient-centric.
We sincerely thank RSU Royal Prima, UNPRI, and all stakeholders who helped make this launch a success. Together, we are shaping the future of personalized healthcare, powered by science and grounded in compassion. It was also a true honour to visit Universitas Prime Indonesia (UNPRI), one of Sumatra’s top universities, and to witness their strong leadership and commitment to clinically accredited, patient-first solutions.
We’re humbled to share that Precision Diagnostics has been recognized as a company under Bio-based Accelerator Program under Bioeconomy Corporation, and has also been officially recognised by the Malaysia Book of Records for:
🏆 𝟏ˢᵗ Clinically Recommended Genome-Wide Pharmacogenomics (2023)
🏆 Largest Clinically Accredited PGx Campaign (2025, with Sunway Multicare Group)
Thank you to RSU Royal Prima, UNPRI, and all collaborators who made this possible. Together, we are shaping a future of healthcare that is precise, predictive, and personal.
